<DOC>
	<DOCNO>NCT00498225</DOCNO>
	<brief_summary>In patient unresectable advanced pancreatic cancer , non-inferiority TS-1 monotherapy superiority GEM + TS-1 combination therapy gemcitabine ( GEM ) verify use survival time .</brief_summary>
	<brief_title>Phase III Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>Pancreatic carcinoma histologically determine adenocarcinoma adenosquamous carcinoma . Advanced unresectable pancreatic ( include pancreatic cancer local progression recurrent pancreatic cancer ) .Presence/absence measurable lesion consider . Patients measurable lesion must undergo diagnostic imaging test within 28 day registration . Patients previous treatment ( radiotherapy , chemotherapy etc ) pancreatic cancer , except resection . Intraoperative radiotherapy resection pancreatic cancer permit , although registration must occur least 4 week radiotherapy . Patients undergone preoperative/postoperative adjuvant chemotherapy may enrol relapse diagnose beyond week 24 final administration ( day 169 day follow final day set day 1 ) . Age : 20 year 79 year . ECOG Performance Status ( PS ) 0 1 . Sufficient function major organ define . ( The follow criterion satisfied laboratory test conduct within 14 day registration . Laboratory test conduct 2 week registration ( weekday ) include . ) White blood cell count≥ 3500/mm3 Neutrophil count≥ 2000/mm3 Hemoglobin≥9.0 g/dL Platelet count≥100000/mm3 Total bilirubin≤ 2.0 mg/dL* *≤ 3.0 mg/dL patient treat biliary drainage obstructive jaundice . AST ALT≤ 150 U/L Serum creatinine≤1.2 mg/dL Creatinine clearance≥50mL/min . ** **Measured value use available . Otherwise , value calculate CockcroftGault method used.Formula estimation : body weight ( kg ) x [ 140 age ( year ) / 72 x serum creatinine ( mg/dL ) ] *Estimated value multiply 0.85 female . Able take capsule orally . No clinically abnormal ECG finding within 28 day ( 4 week ) registration . Voluntarily sign write consent form . Pulmonary fibrosis interstitial pneumonia ( confirm chest Xray within 28 day enrollment ) . Watery diarrhoea . Active infection ( e.g . patient pyrexia 38°C great ) , exclude viral hepatitis . Serious complication ( e.g . heart failure , renal failure , hepatic failure , haemorrhagic peptic ulcer , intestinal paralysis , intestinal obstruction poorly control diabetes ) . Moderate severe ( require drainage ) ascites pleural effusion require treatment . Metastasis CNS . Active double cancer ( synchronous double cancer asynchronous double cancer diseasefree duration 3 year less ) . Carcinoma situ lesion intramucosal carcinoma include active double cancer permit registration . Patients treatment flucytosine , phenytoin warfarin potassium . Pregnant female , possibly pregnant female , female wish become pregnant nursing mother . Males currently attempt produce pregnancy . Severe mental disorder . Judged ineligible physician participation study safety viewpoint .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Pancreatic Cancer</keyword>
</DOC>